What is the Share Price of Gujarat Terce Laboratories Ltd?
- Answer Field
-
The share price of Gujarat Terce Laboratories Ltd for NSE is ₹ 0.00 and for BSE is ₹ 54.26.
BAJAJ BROKING
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, GUJARAT TERCE LABORATORIES LTD share price is currently at ₹ 54.26, which is down by ₹ -3.95 from its previous closing. Today, the stock has fluctuated between ₹ 53.00 and ₹ 61.50. Over the past year, GUJARAT TERCE LABORATORIES LTD has achieved a return of -11.90 %. In the last month alone, the return has been -9.75 %. Read More...
Particulars | DEC 2024 (Values in Cr) |
---|---|
Revenue | 12.68 |
Operating Expense | 11.77 |
Net Profit | 1.01 |
Net Profit Margin (%) | 7.96 |
Earnings Per Share (EPS) | 1.36 |
EBITDA | 1.16 |
Effective Tax Rate (%) | -3.06 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 37.10 | 19.95 | 2.02 | 284.31 | 34.11 / 77.70 |
BLISS GVS PHARMA LTD | 122.65 | 16.07 | 1.27 | 1292.37 | 92.25 / 184.95 |
CIPLA LTD | 1541.00 | 24.94 | 4.38 | 124457.39 | 1310.05 / 1702.00 |
FERMENTA BIOTECH LIMITED | 272.25 | 22.56 | 2.76 | 801.26 | 145.00 / 449.00 |
GLAXOSMITHKLINE PHARMA LT | 2904.45 | 57.61 | 29.41 | 49203.14 | 1924.30 / 3147.45 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 37.10 | 22.35 | 6.30 | 284.31 | 34.11 / 77.70 |
AMRUTAJAN HEALTH LTD | 679.10 | 39.81 | 6.59 | 1963.32 | 548.05 / 861.40 |
ASTRAZENECA PHARMA IND LT | 8795.90 | 131.18 | 32.36 | 21989.75 | 5000.00 / 9199.00 |
BLISS GVS PHARMA LTD | 122.65 | 15.93 | 1.26 | 1292.37 | 92.25 / 184.95 |
Gujarat Terce Laboratories Limited, incorporated in 1985, produces branded generic formulations for the domestic market. Over its more than three-decade business journey, the Company developed an extensive product basket comprising 50 brands covering multiple therapeutic areas which are marketed by its 180+ strong MR team across 13 Indian states. Headquartered in Ahmedabad, the Company has its fully automated facility at Chhatral, in Gandhinagar, Gujarat
By 1986, Terce had established its presence in Gujarat and Rajasthan with a firm footing. In 1992, the management raised public equity to give concrete shape and listed the Company on Bombay Stock Exchange. In same year, Company established extensive manufacturing facility at Chhatral in Gandhinagar, Gujarat. As India heralded new leaps in the pharma sector to become a global force to reckon with by 2005, the Company closely followed the narrative with ferocious growth expanding presence in the domestic and international market.
The Company is an ISO 9001 certified, WHO-GMP compliant operating facility manufactures world-class formulations and healthcare products that feature in acute and chronic therapeutic areas. It engaged into manufacture and sale of pharmaceutical formulations and ayurvedic medicines in India and internationally. It offers products in the form of tablets, capsules, syrups, and injections. The installed capacity of the Company is 270 million tablets and 108 million capsules per annum.
The facility is ISO 9001 certified to manufacture world-class formulations and healthcare products for relief in acute and chronic therapeutic areas. The plant operates on the principles of Lean Manufacturing and Total Quality Management to reduces input costs and improve outcome efficiency. The plant is designed with dedicated HVAC system to prevent contamination and cross contamination. Terce has a separate facility to manufacture Cephalosporin antibiotics range.
The Company otherwise or hence maintains strict and controlled environment for manufacturing and adheres to Good Manufacturing Practices and Good Laboratory Practices to assure highest level of patient safety and outcome efficacy. It has well-defined Total Quality Management System in place to continuously optimize products and processes. Each process is thoroughly monitored and data is collected for analysis which helps in planning corrective and preventive strategies for quality control.
To serve the needs of patients and healthcare professionals, Company focus on early and rapid detection of diseases. Their team of scientists is supported by doctors, patients and marketing team in identifying pressing needs and developing solutions. It has capabilities of innovation across generic drugs to complex formulations, biosimilars and new molecular entity.
The share price of Gujarat Terce Laboratories Ltd for NSE is ₹ 0.00 and for BSE is ₹ 54.26.
The market cap of Gujarat Terce Laboratories Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 40.30 Cr. as of now.
The 52 Week High and Low of Gujarat Terce Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 94.90 and ₹ 44.52.
You can trade in Gujarat Terce Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.
The 1 year returns on the stock has been -11.90%.
Gujarat Terce Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 54.26 as on Apr 30 2025 03:30 PM.
The market cap of Gujarat Terce Laboratories Ltd for NSE ₹ 0.0 & for BSE ₹ 40.30 as on Apr 30 2025 03:30 PM.
As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Gujarat Terce Laboratories Ltd share is 14.63.
As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Gujarat Terce Laboratories Ltd share is 11.94.
You can trade in Gujarat Terce Laboratories Ltd shares with Bajaj Broking by opening a demat account.
To buy Gujarat Terce Laboratories Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Gujarat Terce Laboratories Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found